REFERENCES
- Adelson MO, Hayward R, Bodner G, Bleich A, Gelkopf M, Kreek MJ. Replication of an effective opiate addiction pharmacotherapeutic treatment model: minimal need for modification in a different country. J Maint Addict. 2000;1:5–13.
- Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend. 2006;82:211–217.
- Peles E, Schreiber S, Sason A, Adelson M. Earning “take-home” privileges and long-term outcome in a methadone maintenance treatment program. J Addict Med. 2011;5:92–98.
- Peles E, Schreiber S, Sason A, Adelson M. Long waiting period to enter methadone maintenance treatment: relation to patient characteristics and outcome. Eur Addict Res. 2012;18:149–152.
- Hawks RL Analytical methodology. NIDA Res Monogr. 1986;73:30–42.
- Effective Medical Treatment of Opiate Addiction. NIH Consensus Statement. 1997, November 17–19;15(6):1–38. Available at: http://consensus.nih.gov/1997/1998TreatOpiateAddiction108html.htm
- Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med. 1966;118:304–309.
- Kreek MJ. Plasma and urine levels of methadone. N Y State J Med. 1973;73:2773–2777.
- US Federal Register 21 CRF Part 291 and 42 CRF Part 8 (January 17, 2001). Opioid Drug in Maintenance and Detoxification Treatment of Opiate Addiction; Final Rule.
- Bar-Hamburger R, Shufman E. Changes in psychoactive drug use in Israel from 1990 until 2001. Isr J Psychiatry Relat Sci. 2002;39:79–82.
- McLellan AT, Arndt IO, Metzger DS, Woody GE, O’Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953–1959.
- Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov. 2002;1:710–726.
- Unterwald EM, Horne-King J, Kreek MJ. Chronic cocaine alters brain mu opioid receptors. Brain Res. 1992;584:314–318.
- Unterwald EM, Rubenfeld JM, Kreek MJ. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport. 1994;5:1613–1616.
- Unterwald EM, Kreek MJ, Cuntapay M. The frequency of cocaine administration impacts cocaine-induced receptor alterations. Brain Res. 2001;900:103–109.
- Peles E, Kreek MJ, Kellogg S, Adelson M. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis. 2006;25:43–50.
- Ministry of Health. HIV/AIDS in Israel: Periodic Epidemiological Report 1981–2011 [Hebrew]. Available at: http://www.health.gov.il/PublicationsFiles/AIDS_PeriodicReport2012.pdf.pdf(page4). Published 2012. Accessed June, 2014.
- Israel Central Bureau of Statistics. Persons diagnosed with HIV and AIDS, by exposure category and sex. Available at: http://www.cbs.gov.il/shnaton64/st06_16.pdf . Published 2014. Accessed 2014.
- Zuckerman E. Liver Unit, Carmel Medical Center, Haifa, Israel. Hepatitis C in Israel. Conversation with H. A. Razavi, Center for Disease Analysis, Kromite, Louisville, CO, USA, 2 October 2010.
- Cornberg M, Razavi HA, Alberti A, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 2011;2:30–60.
- Peles E, Rados V, Adelson M. Characterization of former heroin addict patients with Hepatitis C virus antibodies in a methadone maintenance treatment (MMT) clinic in Israel. Subst Use Misuse. 2007;42:1477–1484.